159 related articles for article (PubMed ID: 33882912)
21. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
Petta S; Valenti L; Tuttolomondo A; Dongiovanni P; Pipitone RM; Cammà C; Cabibi D; Di Marco V; Fracanzani AL; Badiali S; Nobili V; Fargion S; Grimaudo S; Craxì A
Hepatology; 2017 Dec; 66(6):1885-1893. PubMed ID: 28741298
[TBL] [Abstract][Full Text] [Related]
22.
Rugwizangoga B; Andersson ME; Kabayiza JC; Nilsson MS; Ármannsdóttir B; Aurelius J; Nilsson S; Hellstrand K; Lindh M; Martner A
Front Cell Infect Microbiol; 2019; 9():340. PubMed ID: 31637221
[TBL] [Abstract][Full Text] [Related]
23. High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815.
Galmozzi E; Facchetti F; Perbellini R; Aghemo A
Clin Microbiol Infect; 2014 Nov; 20(11):O936-8. PubMed ID: 24724563
[TBL] [Abstract][Full Text] [Related]
24. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
Bhushan A; Chinnaswamy S
Gene; 2018 Jul; 664():168-180. PubMed ID: 29705128
[TBL] [Abstract][Full Text] [Related]
25. IFN-λ4: the paradoxical new member of the interferon lambda family.
O'Brien TR; Prokunina-Olsson L; Donnelly RP
J Interferon Cytokine Res; 2014 Nov; 34(11):829-38. PubMed ID: 24786669
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
[TBL] [Abstract][Full Text] [Related]
27. Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus.
Waldenström J; Hellstrand K; Westin J; Nilsson S; Christensen P; Färkkilä M; Mørch K; Langeland N; Norkrans G; Lagging M
Scand J Gastroenterol; 2021 Jul; 56(7):849-854. PubMed ID: 34078234
[TBL] [Abstract][Full Text] [Related]
28. No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.
Fang MZ; Jackson SS; Pfeiffer RM; Kim EY; Chen S; Hussain SK; Jacobson LP; Martinson J; Prokunina-Olsson L; Thio CL; Duggal P; Wolinsky S; O'Brien TR
Clin Infect Dis; 2023 Feb; 76(3):521-527. PubMed ID: 36573283
[TBL] [Abstract][Full Text] [Related]
29. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
[TBL] [Abstract][Full Text] [Related]
30. The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.
Onabajo OO; Muchmore B; Prokunina-Olsson L
J Interferon Cytokine Res; 2019 Oct; 39(10):636-641. PubMed ID: 31241411
[TBL] [Abstract][Full Text] [Related]
31. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
[TBL] [Abstract][Full Text] [Related]
32. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
33. Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs.
Paquin A; Onabajo OO; Tang W; Prokunina-Olsson L
J Interferon Cytokine Res; 2016 Jan; 36(1):30-6. PubMed ID: 26308395
[TBL] [Abstract][Full Text] [Related]
34. Gender-dependent multiple cross-phenotype association of interferon lambda genetic variants with peripheral blood profiles in healthy individuals.
Roy DG; Singh L; Chaturvedi HK; Chinnaswamy S
Mol Genet Genomic Med; 2024 Jan; 12(1):e2292. PubMed ID: 37795763
[TBL] [Abstract][Full Text] [Related]
35. Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
Matic S; Milovanovic D; Mijailovic Z; Djurdjevic P; Sazdanovic P; Stefanovic S; Todorovic D; Popovic S; Vitosevic K; Vukicevic V; Vukic M; Vukovic N; Milivojevic N; Zivanovic M; Jakovljevic V; Filipovic N; Djordjevic N; Baskic D
J Med Virol; 2023 Oct; 95(10):e29152. PubMed ID: 37812032
[TBL] [Abstract][Full Text] [Related]
36. IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.
Fernández-Carrillo C; Coto-Llerena M; González P; Crespo G; Mensa L; Caro-Pérez N; Gambato M; Navasa M; Forns X; Pérez-del-Pulgar S
J Clin Virol; 2014 Oct; 61(2):282-5. PubMed ID: 25130512
[TBL] [Abstract][Full Text] [Related]
37. Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells.
Onabajo OO; Porter-Gill P; Paquin A; Rao N; Liu L; Tang W; Brand N; Prokunina-Olsson L
J Interferon Cytokine Res; 2015 Nov; 35(11):888-900. PubMed ID: 26134097
[TBL] [Abstract][Full Text] [Related]
38. The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.
Holmes JA; Congiu M; Bonanzinga S; Sandhu MK; Kia YH; Bell SJ; Nguyen T; Iser DM; Visvanathan K; Sievert W; Bowden DS; Desmond PV; Thompson AJ
Aliment Pharmacol Ther; 2015 Aug; 42(3):296-306. PubMed ID: 26032235
[TBL] [Abstract][Full Text] [Related]
39. Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4).
Key FM; Peter B; Dennis MY; Huerta-Sánchez E; Tang W; Prokunina-Olsson L; Nielsen R; Andrés AM
PLoS Genet; 2014 Oct; 10(10):e1004681. PubMed ID: 25329461
[TBL] [Abstract][Full Text] [Related]
40. Identification of different malaria patterns due to Plasmodium falciparum and Plasmodium vivax in Ethiopian children: a prospective cohort study.
Seyoum D; Kifle YG; Rondeau V; Yewhalaw D; Duchateau L; Rosas-Aguirre A; Speybroeck N
Malar J; 2016 Apr; 15():208. PubMed ID: 27075667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
